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Rapid Neutrophil Response Controls Fast-Replicating Intracellular Bacteria
but Not Slow-Replicating Mycobacterium tuberculosis
Peter Seiler,1,a Peter Aichele,1,a Ba¨rbel Raupach,1
Bernhard Odermatt,2 Ulrich Steinhoff,1
and Stefan H. E. Kaufmann1
1Max-Planck-Institut fu¨r Infektionsbiologie, Berlin, Germany;
2Department of Pathology, University Hospital Zurich,
Zurich, Switzerland
Being one of the first cells to invade the site of infection, neutrophils play an important
role in the control of various bacterial and viral infections. In the present work, the contri-
bution of neutrophils to the control of infection with different intracellular bacteria was
investigated. Mice were treated with the neutrophil-depleting monoclonal antibody RB6-8C5,
and the time course of infection in treated and untreated mice was compared by using intra-
cellular bacterial species and strains varying in virulence and replication rate. The results
indicate that neutrophils are crucial for the control of fast-replicating intracellular bacteria,
whereas early neutrophil effector mechanisms are dispensable for the control of the slow-
replicating Mycobacterium tuberculosis.
Neutrophilic polymorphonuclear granulocytes (neutrophils)
are among the first cells attracted to the site of infection [1].
In support of local tissue macrophages, neutrophils play a crit-
ical role in the restriction of microbial replication and spread
early after pathogen entry. To do so, neutrophils exhibit a dual
function. First, neutrophils phagocytose pathogens efficiently
[1] and exhibit potent microbicidal activity mediated by gran-
ular enzymes, antimicrobial peptides and proteins, and reactive
intermediates of oxygen and nitrogen [2–6]. As one of the most
efficient phagocytic cells of the immune system, neutrophils
restrict the initial, local replication of numerous pathogens and
thereby delay their systemic spread. Second, neutrophils release
an array of cytokines and chemokines and attract other cells
of the innate as well as the acquired immune system [7–11].
Neutrophils therefore not only contribute to immediate path-
ogen restriction but also focus the specific immune response to
the site of infection, which ultimately achieves control of the
pathogen.
The role of neutrophils in pathogen control in vivo has been
recently rendered accessible for investigation by the neutrophil
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depletion regimen by using the monoclonal antibody (MAb)
RB6-8C5 [12]. Studies in neutrophil-depleted mice have re-
vealed the importance of neutrophils for the initial control of
a variety of pathogens. Neutrophils crucially contribute to the
restriction of extracellular and intracellular bacteria [13–25], as
well as to the control of certain viral and fungal infections [26,
27].
Mycobacterium tuberculosis is a major health problem, killing
2 million people every year [28]. Mononuclear phagocytes and
T cells are crucially involved in the control and local contain-
ment of infection [29]. Less is known about the contribution
of neutrophils to the control of M. tuberculosis. Neutrophils
immigrate quickly to the site of mycobacterial entry [30 and
present authors, unpublished observation], and they are found
in granulomas after infection with M. tuberculosis [31]. How-
ever, conflicting in vitro evidence exists on the question of
whether neutrophils are able to kill M. tuberculosis and hence
actively contribute to growth restriction [32, 33]. We therefore
investigated whether neutrophils participate in the initial con-
trol of M. tuberculosis in vivo by taking advantage of neutro-
phil-depleted mice. Comparisons with infections caused by
other intracellular bacteria have confirmed that neutrophils are
critical for the control of fast-replicating intracellular bacteria
such as Listeria monocytogenes and Salmonella typhimurium
[18, 20, 21, 34]. However, neutrophils apparently do not play
an important role in the initial control of mycobacteria, inde-
pendent of the replication rate and virulence of the species
investigated. Infections with M. tuberculosis, M. bovis bacille
Calmette-Gue´rin (BCG), and M. fortuitum were similarly con-
trolled in neutrophil-depleted and control mice. This ineffi-
ciency of one of the most important lines of innate immune
defense emphasizes the high priority of novel vaccination strat-
egies that ensure a prompt antimycobacterial host response to
partly compensate for the ineffective innate immune response.
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Materials and Methods
Mice. C57BL/6 mice were bred in the animal facilities of the
Max-Planck-Institut at the Bundesamt fu¨r gesundheitlichen Ver-
braucherschutz und Veterina¨rmedizin in Berlin under specific path-
ogen-free conditions. Sex- and age-matched mice were used for all
experiments under conventional housing conditions.
Bacteria. L. monocytogenes EGD Sv 1/2a was originally ob-
tained from G. B. Mackaness and cultured in tryptic soy broth
(Difco, Detroit) overnight at 377C on a rocking platform and di-
rectly used for infection experiments. S. typhimurium SL1344 [35]
was grown in Luria-Bertani (LB) broth (Difco). To ensure inva-
siveness, S. typhimurium was grown in high-osmolarity conditions.
A single colony was inoculated into 5 mL of LB broth containing
0.3 M NaCl and was grown overnight as standing culture. This
culture was diluted 1 : 100, grown to late-logarithmic phase (OD600
of 0.3–0.4), and directly used for infection experiments. M. tuber-
culosis strain Erdman and strain CDC 1551 [36], M. bovis BCG
(Copenhagen), and M. fortuitum (generous gift of K. Feldmann,
Gauting, Germany) were grown in Middlebrook 7H9 broth (Difco)
supplemented with albumin-dextrose complex containing 0.05%
Tween 80 and were stored in aliquots at 2707C. Mice were infected
intravenously (iv) in the lateral tail vein with 103 cfu of L. mono-
cytogenes or S. typhimurium or with 106 cfu of mycobacteria. Sur-
vival was monitored twice daily. For the determination of bacterial
titers, organ homogenates were diluted in PBS for L. monocyto-
genes and S. typhimurium or PBS containing 0.05% Tween 80 for
mycobacteria. Dilutions were plated on LB plates for L. mono-
cytogenes and S. typhimurium and on Middlebrook 7H11 agar
plates supplemented with oleic acid albumin-dextrose complex
(Difco) for mycobacteria and were incubated at 377C.
Antibody and depletion procedure. The neutrophil-depleting
MAb RB6-8C5 was a kind gift from Dr. Robert Coffman [12]. The
hybridoma RB6-8C5 was grown in culture and MAb affinity–
purified over a Protein G-column (Pharmacia, Uppsala, Sweden)
before use. For in vivo neutrophil depletion, mice were treated
intraperitoneally (ip) with 100 mg of MAb RB6-8C5 1 day before
infection. Depletion was verified by immunohistochemistry, blood
smear, cytospin, and fluorescence-activated cell sorter (FACSCal-
ibur; Becton Dickinson, San Jose, CA) analysis.
ELISA. Immuno-Maxi Sorp ELISA plates (Nunc, Wiesbaden,
Germany) were coated overnight with 300 ng of MAb RB6-8C5
per well. Serial 33 dilutions of 103 prediluted mouse sera were
detected by MAb alkaline phosphatase–conjugated goat anti-
mouse immunoglobulin (TAGO, Burlingame, CA). The substrate
for the color reaction was p-nitrophenyl-phosphate disodium
(Sigma, St. Louis), and the color reaction was monitored at 405
nm (ELISA reader SpectraMAX 250; Molecular Devices, Sun-
nyvale, CA).
Immunohistochemistry. Freshly removed organs were im-
mersed in Tissue-Tek O.C.T. (Miles, Elkhart, IN) and snap frozen
in liquid nitrogen. Tissue sections of 5-mm thickness were cut in a
cryostat, placed on siliconized glass slides, air-dried, fixed with
acetone for 10 min, and stored at 2707C. Rehydrated tissue sec-
tions were incubated with primary rat MAb specific for: neutrophils
(PMN: RB6-8C5 [12]), marginal zone metallophilic macrophages
(MM: MOMA-1; Biomedicals, Augst, Switzerland), red pulp mac-
rophages (RPM: F4/80; ATCC HB-198), CD41 T cells (CD4:
YTS191 [37]) or CD81 T cells (CD8: YTS169 [37]). Primary rat
MAbs were detected by a 2-fold sequential incubation with goat
anti-rat immunoglobulin (Caltag, Burlingame, CA) and alkaline
phosphatase–conjugated donkey anti-goat immunoglobulin (Jack-
son Lab, West Grove, PA). CD11c on dendritic cells was stained
with the hamster MAb HL3 (Pharmingen, San Diego). Primary
hamster immunoglobulin was detected by alkaline phospha-
tase–labeled rabbit anti-hamster immunoglobulin (Pharmingen)
followed by alkaline phosphatase–labeled goat anti-rabbit immu-
noglobulin. Secondary and tertiary MAbs were diluted in Tris-
buffered saline (TBS, pH 7.4) containing 5% normal mouse serum.
All other dilutions were made in TBS alone. Incubations were done
at room temperature for 30–40 min; TBS was used for all washing
steps. Alkaline phosphatase was visualized by using naphthol AS-
BI phosphate (Sigma) and New Fuchsin (Merck, Darmstadt, Ger-
many) as substrate. Endogenous alkaline phosphatase activity was
blocked by levamisole (Sigma). All color reactions were performed
in the dark at room temperature for 15 min. Sections were coun-
terstained with hemalum (Merck). Coverslips were mounted with
glycerol/gelatin.
Phagocytosis and respiratory burst assays. Assays for phago-
cytosis and respiratory burst were performed according to the man-
ufacturer’s instructions (Orpegen Pharma, Heidelberg, Germany).
In brief, for the phagocytosis assay, 100 mL of heparinized murine
or human blood was mixed with fluorescein isothiocyanate72 3 10
(FITC)–labeled M. bovis BCG or L. monocytogenes and incubated
at 377 C for 10 min. Control samples were incubated on ice for 10
min. Nonphagocytosed bacteria were quenched with trypan blue.
Cells were permeabilized, fixed, and stained with propidium iodide.
For FACS analysis, eukaryotic cells were gated for high propidium
iodide stain. Neutrophils and monocytes were gated according to
forward and sideward scatter, and FITC fluorescence was moni-
tored. For the burst assay, 100 mL of heparinized murine or human
blood was mixed with unlabeled M. bovis BCG or L. mon-72 3 10
ocytogenes and incubated with di-hydro-rhodamine 123 at 377C for
10 min. Control samples were mixed with medium and di-hydro-
rhodamine 123 only. Cells were permeabilized, fixed, and stained
with propidium iodide. For FACS analysis, eukaryotic cells were
gated for high propidium iodide stain. Neutrophils and monocytes
were gated according to forward and sideward scatter, and FITC
fluorescence was monitored.
Results
Specific depletion of neutrophils by treatment with MAb RB6-
8C5. To investigate the role of neutrophils in the control of
mycobacterial infections, C57BL/6 mice were depleted of neu-
trophils by ip treatment with 100 mg of the MAb RB6-8C5 [12].
Immunohistochemical stainings of spleen sections from treated
and untreated mice were compared 24 h later. Treatment with
the MAb RB6-8C5 led to complete depletion of neutrophils
from the spleen (figure 1A, 1B). Neutrophil depletion was spe-
cific because there was no difference in the immunohistochem-
ical staining observed between MAb RB6-8C5–treated and un-
treated control mice for red pulp macrophages (figure 1C, 1D),
marginal zone metallophilic macrophages (figure 1E, 1F),
Figure 1. Depletion of splenic neutrophils after treatment with monoclonal antibody (MAb) RB6-8C5. C57BL/6 mice were treated intraper-
itoneally with 100 mg of MAb RB6-8C5 at day 21 (A, C, E, G, I, and K) or were left untreated (B, D, F, H, J, and L). Spleens were removed
at day 0, and frozen sections were immunohistochemically stained for neutrophils (PMN, MAb RB6-8C5) (A and B), red pulp macrophages
(RPM, MAb F4/80) (C and D), marginal zone metallophilic macrophages (MM, MAb MOMA-1) (E and F), CD11c1 dendritic cells (DC, MAb
HL3) (G and H), CD41 T cells (CD4, MAb YTS191) (I and J), and CD81 T cells (CD8, MAb YTS169) (K and L). Histological examinations
were performed on 6 animals per condition. ctrl, control. Original magnification was 3100.
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CD11c1 dendritic cells (figure 1G, 1H), CD41 T cells (figure
1I, 1J), or CD81 T cells (figure 1K, 1L). In one experiment,
control C57BL/6 mice were treated with an isotype-matched
control MAb. No difference was observed in comparison with
untreated control mice (data not shown). Therefore, in all sub-
sequent experiments, control mice were left untreated. Com-
pleteness and specificity of neutrophil depletion were further
confirmed by FACS analysis and morphological assessment
using blood smear and cytospin preparations: neutrophils were
efficiently depleted from spleen and blood. No other cell type
was affected by the ip treatment with 100 mg of MAb RB6-
8C5. Higher doses of MAb RB6-8C5 led to a reduction of
CD81 T cells and did not improve depletion of neutrophils (2
mice were tested per condition; data not shown). Therefore,
100 mg of MAb RB6-8C5 was used in all subsequent experi-
ments.
To deplete neutrophils for a prolonged period of time, mice
were treated ip repetitively with 100 mg of MAb RB6-8C5 at
3-day intervals, and spleen sections were analyzed for the pres-
ence of neutrophils by immunohistochemistry. As shown in fig-
ure 2A, neutrophil depletion lasted for 3–4 days, independent
of whether mice had been treated once or twice with MAb
RB6-8C5. Spleens were repopulated with neutrophils by day 6
after treatment. Repetitive treatment did not lead to prolonged
neutrophil depletion, most probably because of a strong anti-
body response against the rat MAb RB6-8C5. Sera of MAb
RB6-8C5–treated mice exhibited a strong antibody response
against the depleting antibody that was already detectable by
ELISA between days 3 and 6 after treatment (figure 2B). Be-
cause repetitive treatment with MAb RB6-8C5 did not prolong
neutrophil depletion, mice were treated once with 100 mg of
MAb RB6-8C5 in all subsequent experiments.
Survival of neutrophil-depleted mice after infection with intra-
cellular bacteria. To investigate the impact of neutrophils on
control of infection with intracellular bacteria, mice were
treated ip with 100 mg of MAb RB6-8C5 24 h before infection
or mice were left untreated. Mice were infected iv with 103 cfu
of S. typhimurium or L. monocytogenes or 106 cfu of M. tu-
berculosis strain Erdman, M. tuberculosis strain CDC 1551, M.
bovis BCG, or M. fortuitum, and survival was monitored. A
marked reduction in survival time of MAb RB6-8C5–treated
mice compared with untreated control mice was observed after
infection with the fast-replicating intracellular bacteria S. ty-
phimurium and L. monocytogenes (figure 3A, 3B). In contrast,
depletion of neutrophils during the initial phase of the immune
response did not affect survival rate of mice after mycobacterial
infection, independent of the virulence and replication rate of
the bacterial species or strain tested (figure 3C–3F). Mice in-
fected with M. tuberculosis strain Erdman or CDC 1551 started
to die beginning from day 180 postinfection, irrespective of
initial neutrophil depletion (data not shown).
Development of bacterial titers in neutrophil-depleted mice.
The results presented in the previous paragraph are reflected
in the development of bacterial load in various organs at dif-
ferent time points after infection. Three time windows were
analyzed: early time points (10 min and 6 h) as a measure of
the immediate filter function of neutrophils; intermediate time
points (24 h and 48 h) as a measure of the bactericidal effector
functions of neutrophils; and late time points (6 days and 21
days) as a measure of the impact of neutrophils on the overall
immune balance. As shown in figure 4, mice treated with MAb
RB6-8C5 had a higher bacterial burden than untreated control
mice after infection with the fast-growing S. typhimurium and
L. monocytogenes. In contrast, no substantial differences in bac-
terial numbers in the spleen, liver, and kidney were observed
between MAb RB6-8C5–treated and untreated control mice
after infection with slow-growing mycobacteria, although bac-
terial counts in the lung may have been somewhat higher in
the treated animals (figure 5A–5L). However, after infection
with fast-growing M. fortuitum, bacterial load in the lung was
increased by 1–2 log10 in neutrophil-depleted mice compared
with untreated control mice on day 7 (figure 5O).
Phagocytic activity and activation of neutrophils. Because
neutrophil depletion during the initial phase of infection had
no impact on the control of mycobacteria, the capacity of neu-
trophils to phagocytose mycobacteria was investigated. FITC-
labeled M. bovis BCG or L. monocytogenes were incubated with
peripheral blood from C57BL/6 mice at 377C for 10 min. After
quenching of nonphagocytosed bacteria, cells were analyzed by
FACS for ingested bacteria after gating on living neutrophils
and monocytes by forward/sideward scatter. After a 10-min
incubation, neutrophils had already phagocytosed M. bovis
BCG as well as L. monocytogenes, whereas monocytes had not
yet phagocytosed the bacteria (figure 6A). Phagocytosis of M.
bovis BCG was at least as efficient as phagocytosis of L. mono-
cytogenes, although direct comparison was difficult, because
the fluorescence intensity of FITC-labeled M. bovis BCG was
much higher than that of FITC-labeled L. monocytogenes, as
revealed by fluorescence microscopy (data not shown). Phago-
cytosis of M. bovis BCG and L. monocytogenes by human neu-
trophils was similar and also not detectable by human blood
monocytes after 10 min of incubation with bacteria (figure 6B).
After 30 min of incubation, blood monocytes had started to
phagocytose M. bovis BCG and L. monocytogenes, whereas
neutrophils had begun to undergo apoptosis, as revealed by
loss of propidium iodide stain (data not shown).
Because neutrophils efficiently phagocytosed mycobacteria,
activation of neutrophils upon phagocytosis of M. bovis BCG
and L. monocytogenes was compared. Mouse and human pe-
ripheral blood leukocytes were incubated with M. bovis BCG
or L. monocytogenes in the presence of fluorochrome di-hydro-
rhodamine 123. Upon oxidation, di-hydro-rhodamine 123 turns
into the fluorescent mono-hydro-rhodamine as a measurement
for the production of reactive oxygen and nitrogen interme-
diates [38–44]. As shown in figure 7, mouse and, more evident-
ly, human neutrophils exhibited considerably less fluorescent
Figure 2. A, Depletion of splenic neutrophils after single or repetitive treatment with monoclonal antibody (MAb) RB6-8C5. C57BL/6 mice
were treated intraperitoneally (ip) with 100 mg of MAb RB6-8C5 once at day 0 (a and c) or twice at days 0 and 3 (b and d). Spleens were removed
at day 3 (a and b) or day 6 (c and d), respectively, and frozen sections were immunohistochemically stained for neutrophils. Original magnification,
3100. B, Antibody response against MAb RB6-8C5. Serum samples from mice treated ip with 100 mg of MAb RB6-8C5 at days 0 and 3 (n) or
from untreated control (ctrl) mice (V) were collected at the indicated time points and analyzed by ELISA for antibodies against MAb RB6-8C5.
Titer steps represent 33 dilutions of 103 prediluted sera. Values represent individual mice. Shown is 1 representative out of 2 experiments.
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Figure 4. Bacterial load in neutrophil-depleted mice infected with
fast-replicating Salmonella typhimurium and Listeria monocytogenes.
C57BL/6 mice were treated intraperitoneally with 100 mg of monoclonal
antibody (MAb) RB6-8C5 at day 21 (n) or were left untreated (V).
At day 0, mice were infected intravenously with 103 cfu of S. typhi-
murium (A–D) or with 103 cfu of L. monocytogenes (E–H). Bacterial
numbers in organs were determined at the indicated time points. Values
are log cfu per organ of individual mice; lines represent mean cfu per
group of MAb RB6-8C5–treated mice (dotted lines) and of control
(ctrl) mice (solid lines). D Mice were dead by this time point. Each
experiment consisted of 4 mice per group. The detection limit of the
assay is log . Shown is 1 representative of 2 experiments. Valuescfu = 1
were compared using a 2-tailed Student’s t test. Asterisks indicate sta-
tistically significant differences (* ; ** ).P ! .01 P ! .001
Figure 3. Survival of neutrophil-depleted mice after infection with
intracellular bacteria. C57BL/6 mice were treated intraperitoneally with
100 mg of monoclonal antibody (MAb) RB6-8C5 at day 21 (n) or
were left untreated (V). At day 0, mice were infected intravenously
with 103 cfu of Salmonella typhimurium (A) or Listeria monocytogenes
(B) or 106 cfu of Mycobacterium tuberculosis strain Erdman (C) or
strain CDC 1551 (D), M. bovis bacille Calmette-Gue´rin (E), or M.
fortuitum (F), respectively, and survival was monitored. Each experi-
ment consisted of 5 mice per group; shown is 1 representative out of
2 experiments.
mono-hydro-rhodamine after phagocytosis of M. bovis BCG
than after phagocytosis of L. monocytogenes, indicating less
production of reactive oxygen and nitrogen intermediates after
infection by M. bovis BCG. This suggests that slow-growing
M. bovis BCG activated neutrophils less efficiently than did
L. monocytogenes.
Discussion
In the present study, neutrophil depletion of mice revealed
different impacts on the control of fast-replicating versus slow-
replicating intracellular bacteria. Whereas innate control of in-
fection with fast-replicating S. typhimurium and L. monocyto-
genes depended on neutrophils, control of slow-replicating M.
tuberculosis and M. bovis BCG was independent of neutrophils
under the conditions used in this study. An intermediate phe-
notype was observed after infection with the fast-replicating,
avirulent M. fortuitum. Survival rates were not influenced by
neutrophil depletion; however, increased bacterial numbers in
the lung were observed.
The in vivo depletion of neutrophils in mice was achieved
by treatment with the MAb RB6-8C5. This MAb has been used
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Figure 5. Bacterial load in neutrophil-depleted mice infected with mycobacteria. C57BL/6 mice were treated intraperitoneally with 100 mL of
monoclonal antibody (MAb) RB6-8C5 at day21 (n) or were left untreated (V). At day 0, mice were infected intravenously with 106 cfu of
Mycobacterium tuberculosis strain Erdman (A–D) or strain CDC 1551 (E–H), M. bovis bacille Calmette-Gue´rin (I–L), or M. fortuitum (M–P).
Bacterial numbers in organs were determined at the indicated time points. Values are log cfu per organ of individual mice. Lines represent mean
cfu per group of MAb RB6-8C5–treated mice (dotted lines) and of control (ctrl) mice (solid lines). Each experiment consisted of 4 mice per group.
The detection limit of the assay is log . Shown is 1 representative of 2 experiments. Values were compared by using a 2-tailed Student’s tcfu = 1
test. Asterisks indicate statistically significant differences (* ; ** ).P ! .01 P ! .001
for studying the contribution of neutrophils to the control of
a variety of pathogens [14–27, 34]. Treatment protocols differed
in dose and frequency of MAb application. A possible cross-
depletion of other leukocyte subsets, especially of CD81 T cells,
has been reported after high dose or repetitive treatment with
MAb RB6-8C5 [22, 25, 26]. Since CD81 T cells play an im-
portant role in the control of M. tuberculosis [29, 45–47], we
tested the MAb application protocol for specificity of neutro-
phil depletion. In our studies, the single ip treatment with 100
mg of MAb RB6-8C5 led to efficient and specific neutrophil
depletion. However, higher doses or repetitive MAb treatment
did not prolong the neutrophil depletion, compared with single
treatment, but partially depleted CD81 T cells, as judged by
immunohistochemistry and FACS analysis (data not shown).
Our study therefore focused on the contribution of neutrophils
to the antibacterial immune defense during the initial phase of
the infection. Considering the problems caused by repetitive
MAb RB6-8C5 treatment, protocols for long-term neutrophil
depletion remain to be established very carefully.
The observed role of neutrophils in efficient control of in-
fection with S. typhimurium and L. monocytogenes comple-
ments published literature [18, 20, 21]. In extension, the present
study indicates that transient (3–4 days) neutrophil depletion
of mice had no impact on infections with slow-growing my-
cobacteria. Although the existing in vitro evidence [32, 33] is
conflicting on whether neutrophils contribute to the control of
M. tuberculosis and by which mechanisms, our data indicate
that in vivo, neutrophils do not contribute to the initial restric-
tion of M. tuberculosis. Although neutrophils were highly ef-
ficient in the phagocytosis of mycobacteria, the respiratory
burst, a measure of neutrophil activation, was smaller after
phagocytosis of M. bovis BCG than after phagocytosis of L.
monocytogenes. Possibly, mycobacteria partially suppressed ac-
tivation of neutrophils and their subsequent oxidative and non-
oxidative microbicidal activity. This is in agreement with the
finding that several mycobacterial components interfere with
activation of mononuclear phagocytes [48, 49]. Also, taking
into account the short life span of neutrophils [10], a delayed
activation of neutrophils may allow slow-growing mycobacteria
to survive neutrophil effector functions.
Slow-growing mycobacteria exhibited a general resistance
against murine neutrophil activity, independent of their viru-
lence for humans. No differences in survival rate or develop-
ment of bacterial numbers were observed in neutrophil-depleted
mice after infection with the virulent M. tuberculosis strains
Erdman or CDC 1551 when compared with the nonvirulent
M. bovis BCG. Furthermore, no difference was observed after
infection with the M. tuberculosis laboratory strain Erdman and
the clinical isolate CDC 1551 [36]. This clinical isolate has been
identified as the cause of an M. tuberculosis outbreak because
of its high transmission rate. To the extent that murine and
human neutrophils are functionally comparable, our data sug-
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Figure 6. Phagocytosis of intracellular bacteria by neutrophils. (A) 100 mL of mouse or (B) 100 mL of human heparinized peripheral blood
was incubated with fluorescein isothiocyanate (FITC)–labeled Mycobacterium bovis bacille Calmette-Gue´rin or FITC-labeled Listeria72 3 10
monocytogenes at 377C for 10 min. Phagocytosis of bacteria was detected by FACS analysis after gating on viable neutrophils or monocytes by
forward/sideward scatter. Dotted lines represent control incubation at 07C. Shown is 1 representative experiment of 3.
Figure 7. Neutrophil activation for respiratory burst upon phago-
cytosis of intracellular bacteria. One hundred microliters of mouse (A
and C) or human (B and D) heparinized peripheral blood was mixed
with cfu of Mycobacterium bovis bacille Calmette-Gue´rin (A72 3 10
and B) or Listeria monocytogenes (C and D) and incubated with di-
hydro-rhodamin 123 (Orpegen, Heidelberg, Germany) at 377C for 10
min. Oxidation of di-hydro-rhodamin 123 by neutrophil-induced ROI
and RNI after phagocytosis of bacteria was detected by fluorescence-
activated cell sorter analysis after gating on viable neutrophils by for-
ward/sideward scatter. Dotted lines represent control incubation at
377C with medium and di-hydro-rhodamin 123 only. Shown is 1 rep-
resentative experiment of 3.
gest that the elevated transmission rate was not because of
increased resistance against neutrophil microbicidal activities.
In the present study, no impact of neutrophils during the
initial phase of immune defense against slow-growing myco-
bacteria was observed, either at early or at late stages of in-
fection. Results from early and intermediate time points exclude
filter function and direct microbicidal effector function of neu-
trophils, respectively. Results from late time points of infection
indicate that neutrophil depletion did not influence the balance
between immune response and bacterial kinetics. This might
be because of the following reasons: (1) the balance can be
maintained redundantly by other members of the innate im-
mune system, such as tissue macrophages, or (2) the balance
is not critically shifted due to the short duration of the neu-
trophil depletion.
The findings of the present study are consistent with obser-
vations from neutropenic patients. Neutropenia can result from
exposure to x-rays or chemotherapy or can result from inherited
genetic defects [11, 50–54]. Neutropenic patients reflect a more
chronic neutropenia than do mice experimentally depleted of
neutrophils. Nevertheless, patients mainly are infected with fast-
replicating bacteria and fungi [11, 51–53, 55]. Few reports de-
scribed infection of neutropenic patients with M. fortuitum,
which may reflect our observation of increased M. fortuitum
burden in the lung of neutrophil-depleted mice. No reports are
available to demonstrate an increased susceptibility of neutro-
penic patients toward M. tuberculosis. The seemingly neutro-
phil-independent control of M. tuberculosis infection in non-
neutropenic patients, therefore, might be caused by a partial
suppression of neutrophil activation mediated by mycobacteria,
as suggested by the results in the present study. However, further
investigations are needed to clarify how such suppression is
achieved.
In summary, the dual function of neutrophils, immediate
pathogen restriction and local focusing of the specific immune
response, is vital for the control of fast-replicating intracellular
bacteria but apparently subordinate for the control of slow-
replicating intracellular bacteria. This emphasizes the impor-
tance of the development and improvement of an effective vac-
cination strategy against M. tuberculosis, enabling the memory
type of the acquired immune response to overcome the insuf-
ficient innate immune response mediated by neutrophils.
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